• No results found

[PDF] Top 20 Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis

Has 10000 "Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis" found on our website. Below are the top 20 most common "Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis".

Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis

Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis

... sensitive biomarkers and prognostic indicators, a long preclinical phase, and lack of effective disease modifying ...ease neuroimaging initiative (ADNI, Jack et ...the Neuroimaging society in ALS ... See full document

239

Evaluation of antioxidant and neuroprotective therapies in a mouse model of amyotrophic lateral sclerosis

Evaluation of antioxidant and neuroprotective therapies in a mouse model of amyotrophic lateral sclerosis

... 2013, 'Mutant copper-zinc superoxide dismutase SOD1 induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron p[r] ... See full document

261

Amyotrophic lateral sclerosis mimic ‎syndromes

Amyotrophic lateral sclerosis mimic ‎syndromes

... multiple sclerosis a both of UMN and LMN involvement may be seen in the setting of plaque formation at root exit zones, combined with central nervous system (CNS) ...so neuroimaging may be essential in the ... See full document

7

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

... immunological evaluation 24 hours after cell engraftment reported sig- nificant reduction in activated lymphocytes and cytokine production, indicating immediate immunomodulatory effects of the hMSCs ... See full document

10

New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis

New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis

... Markers of inflammation and immune activation in CSF Inflammation in the CNS and the systemic circulation is considered to be a key factor in the pathogenesis of ALS [26, 27]. Inflammation in ALS is resulted from ... See full document

8

Risk factors for amyotrophic lateral sclerosis

Risk factors for amyotrophic lateral sclerosis

... intensive evaluation of multiple risk factors within clinical and population-based case-control studies of ALS, where many different types of information could be collected at the time of ... See full document

13

Respiratory measures in amyotrophic lateral sclerosis

Respiratory measures in amyotrophic lateral sclerosis

... in ALS patients and are recommended for patients with severe bulbar impairment (47,48). Nocturnal pulse oximetry, which involves measuring oxygen saturation throughout the night via transcutaneous finger probes (49), and ... See full document

11

Controversies and priorities in amyotrophic lateral sclerosis

Controversies and priorities in amyotrophic lateral sclerosis

... candidate biomarkers (summarised in panel 2),103, 104 and 105 the revised ALS functional rating score (ALSFRS-R; panel 3) is a frequently used outcome measure in therapeutic ... See full document

31

CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis

CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis

... ALS: Amyotrophic lateral sclerosis; ALSFRS: ALS functional rating scale; A β -42: Amyloid beta; BDNF: Brain-derived neurotrophic factor; FTD: Frontotemporal dementia; GFAP: Glial fibrillary acidic ... See full document

5

Interneuron dysfunction in amyotrophic lateral sclerosis

Interneuron dysfunction in amyotrophic lateral sclerosis

... Clinical TMS studies have given incredible insight into the time frame and regional involvement of inhibitory/excitatory disturbance in the cortex (Eisen et al 1993, Zanette et al 2002b, Vucic & Kiernan 2006b, Vucic ... See full document

157

Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis

Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis

... of Amyotrophic Lateral Sclerosis (ALS), an adult onset progressive fatal neurodegenerative ...ideal biomarkers may offer tools for rapid diagnosis, monitoring ... See full document

9

Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis.

Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis.

... We studied 21 consecutive patients with ALS who were recruited from Department of Neurology, Indira Gandhi Medical College, Shimla, Himachal Pradesh Patients with ALS (n = 21; women = 7; men = 14; mean age = 51.28 ± ... See full document

7

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid

... We demonstrated that exosomal mRNAs can feasibly be biomarkers for diagnosis of ALS. CUEDC2 was the most dramatically increased exosomal mRNA in CSF from ALS patients. At least, inflammatory cytokines such as IL-6 ... See full document

11

Neuropsychological study of amyotrophic lateral sclerosis and parkinsonism-dementia complex in Kii peninsula, Japan

Neuropsychological study of amyotrophic lateral sclerosis and parkinsonism-dementia complex in Kii peninsula, Japan

... Neuroimaging studies of the head with magnetic res- onance imaging (MRI) and angiography (MRA), and brain regional perfusion as assessed by single photon emission computed tomography (SPECT) were per- formed for ... See full document

8

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

... establish biomarkers sensitive to diagnosis, prognostic stratification and disease activity of ALS (Table ...of amyotrophic lateral sclerosis (ALS) currently depends upon the opinion of an ... See full document

25

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis

... Nevertheless, there are many remaining challenges. New techniques need to be harnessed and integrated into clinical research and practice. New acquisition schemes and analysis procedures require standardization and ... See full document

9

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis

... (ALS): Amyotrophic lateral sclerosis; (UMN): upper motor neurone; (LMNs): lower motor neurone; (Ub-IR): ubiquitin-immunoreactive; (TDP43-IR): TDP-43 immu- noreactive; (EMG): electromyography; (PMA): ... See full document

22

Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U

Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U

... AD: Alzheimer ’ s disease; aFTLD-U: Atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions; ALS: Amyotrophic lateral sclerosis; ALS-FUS: Amyotrophic lateral sclero[r] ... See full document

11

Cognitive and behavioral features of c9FTD/ALS

Cognitive and behavioral features of c9FTD/ALS

... familial amyotrophic lateral sclerosis (ALS) has been associated with mutations in genes encoding Cu/Zn superoxide dismutase-1 (SOD1), TARDBP, and FUS ... See full document

15

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon

... Some limitations of this study include the small sample size and the adherence evaluation and data collection methods. Using dispensing dates to evaluate adherence does not take into consideration other factors ... See full document

5

Show all 10000 documents...